SCHEMBL4477400

SCHEMBL4477400

OC(Cc1ccnc(Cl)c1)(Cc1ccnc(Cl)c1)c1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.49
LOX P28300 1/20 0.45
LOXL3 P58215 1/20 0.45
LOXL2 Q9Y4K0 1/20 0.45
NR3C1 P04150 1/20 0.41
USP2 O75604 1/20 0.38
RAB9A P51151 1/20 0.38
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP19A1 P11511 2/20 0.35
MRGPRX4 Q96LA9 1/20 0.34
MAPK14 Q16539 3/20 0.33
MAPK13 O15264 2/20 0.33
MAPK12 P53778 2/20 0.33
MAPK11 Q15759 2/20 0.33
AR P10275 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
NR3C2 P08235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7366233 0.77 USP2 (0.58) USP2RAB9ACYP2C9CYP2C19CYP1A2
SCHEMBL31293733 0.73 LOXL2 (0.57) RECQLLOXLOXL3LOXL2GRM5
SCHEMBL21575050 0.73 NR3C1 (0.46) RECQLLOXLOXL3LOXL2NR3C1
SCHEMBL30211295 0.72 USP2 (0.51) USP2RAB9ACYP2C9CYP2C19CYP1A2
SCHEMBL2887435 0.70 GRM5 (0.50) RECQLLOXLOXL3LOXL2GRM5
SCHEMBL2980415 0.70 RAB9A (0.50) RECQLLOXLOXL3LOXL2RAB9A
SCHEMBL12017629 0.70 LOX (0.57) RECQLLOXLOXL3LOXL2NR3C2
SCHEMBL21575073 0.69 NR3C1 (0.43) RECQLNR3C1USP2RAB9ACYP2C9
SCHEMBL25388344 0.68 LOXL2 (0.50) RECQLLOXLOXL3LOXL2AR
SCHEMBL15153914 0.68 FDPS (0.51) RECQLLOXLOXL3LOXL2GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582660-B2 2-thio-substituted imidazole derivatives and their use in pharmaceutics C-A-I-R BIOSCIENCES GMBH (DE) 2009-09-01 US disclosed
US-20060235054-A1 2-Thio-substituted imidazole derivatives and their use in pharmaceutics MERCKLE-GMBH (DE) 2006-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235054-A1 2-Thio-substituted imidazole derivatives and their use in pharmaceutics IL2, TPMT, IFNG RECQL 1569/4885LOX 2706/4885LOXL3 4163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.